Gabriel Capellá

Gabriel Capellá obtained his MD degree at the University of Barcelona in 1983. He trained as a general and digestive surgeon at the Hospital de Sant Pau, Barcelona.

He has worked at the Catalan Institute of Oncology since 1998, as Director of the Translational Research Laboratory until 2011, and as Director of the Hereditary Cancer Program from 2010. His main interest is the study of the genetic basis of gastrointestinal cancer focusing in novel technologies for the clinical management of patient at risk of developing GI Cancer. He is co-author of more than 250 publications in international peer-reviewed journals.

He is Vice-Director for Research and Innovation at the Catalan Government’s Department of Health, and he is currently the Director of the Bellvitge Biomedical Research Institute. He is co-founder of VCN Biosciences, a spin-off aimed at developing new cancer therapies based on oncolytic adenoviruses.